Colette Knight is an Endocrinology/Metabolic physician affiliated with Hackensack University Medical Center. OpenAlex indexes 20 publications with 1,356 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
150 Overlook Ave
Hackensack, NJ 076012206
Telephone
201-489-5999Registry record last updated 12 Jul 2019.
Clinical trials
- Continuous Glucose Monitoring and Diabetes
Sponsor: Hackensack Meridian Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202514 payments
- Insulet CorporationProgram year20254 payments
- Tandem Diabetes Care, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
44.5%RANK Ligand Inhibitor44.5%Denosumab99%Prolia1%Part D + Part B≥16 patientsMetabolism & gastrointestinal
37.4%Insulin Analog12.2%Lantus Solostar26%Basaglar Kwikpen U-10014%Humalog Kwikpen U-10014%Tresiba Flextouch U-1008%Humalog Kwikpen U-2007%Novolog Flexpen6%Tresiba Flextouch U-2005%Insulin Lispro Kwikpen U-1004%Fiasp Flextouch3%Humalog3%Novolog3%Toujeo Max Solostar3%Toujeo Solostar3%Part D<11 patientsGLP-1 receptor agonist8.7%Ozempic61%Mounjaro23%Trulicity12%Rybelsus5%Part D<11 patients+ 10 more classes in this area
Hormonal (systemic)
9.3%l-Thyroxine7%Levothyroxine Sodium93%Synthroid8%Part D<11 patientsVasopressin Analog0.5%Desmopressin Acetate100%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 843 Patient Perception of Gestational Diabetes Mellitus And Its Influence on Adherence to Postpartum Diabetes Screening
American Journal of Obstetrics and Gynecology
2024 - Stem Cell Educator therapy in type 1 diabetes: From the bench to clinical trials
Autoimmunity Reviews
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Parrillo, MD
Hackensack University Medical Center
Andre Goy, MD
Hackensack University Medical Center
David Vesole, MD
Hackensack University Medical Center
Caron Rockman, MD
Hackensack University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”